GlassScriptPhysician profile
Davey L Prout
NPI 1780843607
$10,865.00
in general payments reported to CMS, 2019-2025
52 companies · $1,685 in 2025
The $1,685 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,594 · 2020: $1,097 · 2021: $1,279 · 2022: $1,830 · 2023: $1,670 · 2024: $1,710 · 2025: $1,685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,065.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,474.87 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,027.11 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $909.77 | 2019-2025 | |
| Abiomed | $840.46 | 2019-2025 | Impella |
| Amgen INC. | $776.99 | 2019-2025 | Repatha, Repatha, Otezla |
| Merck Sharp & Dohme LLC | $620.30 | 2022-2025 | Verquvo, Capvaxive, Winrevair |
| Pfizer INC. | $560.92 | 2019-2025 | |
| Esperion Therapeutics, INC. | $553.14 | 2020-2025 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $544.18 | 2019-2025 | Wainua, Farxiga, Fasenra |
| E.R. Squibb & Sons, L.L.C. | $532.30 | 2019-2025 | Eliquis, Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $370.91 | 2021-2025 | |
| Chiesi USA, INC. | $269.19 | 2020-2024 | Kengreal, Cleviprex |
| Boehringer Ingelheim Pharmaceuticals, INC. | $268.10 | 2019-2025 | Jardiance |
| Boston Scientific Corporation | $199.72 | 2023-2025 | Opticross, Rotapro, Watchman Flx |
| Kestra Medical Technology Services, INC. | $177.73 | 2022-2025 | Assure Wcd |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $145.33 | 2019-2021 | |
| Abbott Laboratories | $137.10 | 2020-2024 | Diamondback Coronary, Pressurewire |
| Heartflow, INC. | $131.03 | 2024 | |
| Medtronic Vascular, INC. | $123.83 | 2019 | |
| Novo Nordisk INC | $99.19 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $87.38 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $84.56 | 2019-2021 | |
| Angiodynamics, INC. | $79.28 | 2023 | Auryon Laser System 100-120 Vac |
| Philips North America LLC | $73.62 | 2022-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Ck4) Mcot |
| Scpharmaceuticals INC. | $64.35 | 2024-2025 | |
| Shockwave Medical, INC | $64.03 | 2022 | |
| Cleerly, INC. | $50.98 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Lundbeck LLC | $47.48 | 2019-2020 | |
| Inspire Medical Systems, INC. | $44.98 | 2024 | Inspire |
| Baxter Healthcare | $40.94 | 2022-2025 | Hillrom - Carnation Ambulatory Monitor |
| Kiniksa Pharmaceuticals, LTD. | $40.08 | 2022-2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $38.50 | 2024 | Arcalyst |
| Lilly USA, LLC | $33.25 | 2025 | Jardiance, Zepbound |
| Actelion Pharmaceuticals US, INC. | $25.06 | 2025 | Uptravi |
| Edwards Lifesciences Corporation | $23.60 | 2025 | |
| Itamar Medical INC | $23.58 | 2023 | Watchpatone |
| Penumbra, INC. | $22.76 | 2022 | |
| W. L. Gore & Associates, INC. | $21.88 | 2021 | |
| Exact Sciences Corporation | $21.79 | 2025 | Cologuard Collection Kit |
| Irhythm Technologies, INC. | $20.42 | 2024 | Zio Monitor, Zio Xt Patch |
| Inari Medical, INC. | $19.62 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Takeda Pharmaceuticals U.S.A., INC. | $19.58 | 2021 | |
| Alexion Pharmaceuticals, INC. | $19.40 | 2023 | Koselugo |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.30 | 2025 | Caplyta |
| Becton, Dickinson and Company | $18.22 | 2024 | Denali Vena Cava Filter |
| Astellas Pharma US INC | $17.04 | 2020 | |
| Cardiovascular Systems INC. | $16.17 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $13.72 | 2023 | Nuedexta |
| Arbor Pharmaceuticals, INC. | $13.67 | 2019 | |
| Athena Bioscience, LLC | $13.07 | 2022 | |
| Medtronic, INC. | $12.86 | 2023 | Micra |
| Genzyme Corporation | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Davey Prout listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.